Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04410653
Title Afatinib in Advanced NRG1-Rearranged Malignancies
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors German Cancer Research Center
Indications
Therapies
Age Groups: senior | adult
Covered Countries DEU

Facility Status City State Zip Country Details
NCT Dresden Dresden 01307 Germany Details
NCT Heidelberg Heidelberg 69120 Germany Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field